Thompson Street Capital Partners (TSCP) has partnered with management to acquire Memphis-based Transnetyx, Inc., a leading independent genetic diagnostic laboratory specializing in automated genotyping. Terms of the transaction were not disclosed.
Transnetyx (www.transnetyx.com) provides genotyping services to the pharmaceutical and academic research communities. The Company pioneered the automation of genotyping and has genotyped more than 16 million samples in 24 or 72 hours, with 99.97% accuracy. It has also built an inventory of more than 20,000 assays and more than 10,000 MGI and JAX lines.
Said Jim Cooper, Managing Partner, TSCP, “We’re excited to be partnering with the management of Transnetyx. The Company is highly respected in the industry and enjoys a well-deserved reputation for excellence, innovation and customer service.” Added Mr. Cooper, “Transnetyx’s ongoing mission – in which they’ve been continuously successful – is to help scientists accelerate their research with fast and accurate real-time PCR genotyping. We look forward to being part of the continued growth of Transnetyx.”